Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/r based antiretroviral therapy.
We investigated whether there are differences in the effects on microbial translocation (MT) and enterocyte damage by different antiretroviral therapy (ART) regimens after 1.5 years and whether antibiotic use has impact on MT. In a randomized clinical trial (NCT01445223) on first line ART, patients...
Main Authors: | Jan Vesterbacka, Piotr Nowak, Babilonia Barqasho, Samir Abdurahman, Jessica Nyström, Staffan Nilsson, Hiroyuki Funaoka, Tatsuo Kanda, Lars-Magnus Andersson, Magnus Gisslèn, Anders Sönnerborg |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3557242?pdf=render |
Similar Items
-
Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
by: Vandercam Bernard, et al.
Published: (2010-05-01) -
Microbial translocation contribute to febrile episodes in adults with chemotherapy-induced neutropenia.
by: Michelle Wong, et al.
Published: (2013-01-01) -
Efavirenz and Lopinavir/Ritonavir Alter Cell Cycle Regulation in Lung Cancer
by: Rahaba Marima, et al.
Published: (2020-08-01) -
Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients.
by: Amanda Häggblom, et al.
Published: (2017-01-01) -
Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China
by: Bin Su, et al.
Published: (2019-12-01)